tiprankstipranks
Medipal Holdings Corporation (MEPDF)
OTHER OTC:MEPDF
Holding MEPDF?
Track your performance easily

Medipal Holdings (MEPDF) Income Statement

2 Followers

Medipal Holdings Income Statement

Last quarter (Q3 2022), Medipal Holdings's total revenue was ¥882.02B, an increase of 2.08% from the same quarter last year. In Q3, Medipal Holdings's net income was ¥12.52B. See Medipal Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
¥ 3.35T¥ 3.36T¥ 3.29T¥ 3.21T¥ 3.25T¥ 3.18T
Cost of Revenue
¥ 3.13T-¥ 3.07T¥ 3.00T¥ 3.02T¥ 2.95T
Gross Profit
¥ 223.56B-¥ 217.44B¥ 214.26B¥ 236.74B¥ 232.50B
Operating Expense
¥ 177.44B-¥ 171.82B¥ 175.68B¥ 183.63B¥ 182.67B
Operating Income
¥ 46.13B-¥ 45.63B¥ 38.58B¥ 53.11B¥ 49.83B
Net Non Operating Interest Income Expense
¥ 115.00M-¥ 161.00M¥ 128.00M¥ 57.00M¥ 19.00M
Other Income Expense
------
Pretax Income
¥ 61.73B-¥ 57.28B¥ 49.24B¥ 75.54B¥ 63.46B
Tax Provision
¥ 22.08B-¥ 18.09B¥ 15.62B¥ 24.31B¥ 18.04B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
¥ 30.44B-¥ 29.42B¥ 23.93B¥ 37.97B¥ 34.36B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
¥ 4.13B-¥ 4.26B¥ 4.42B¥ 4.35B¥ 4.27B
Total Expenses
¥ 3.30T-¥ 3.25T¥ 3.17T¥ 3.20T¥ 3.13T
Net Income From Continuing And Discontinued Operation
¥ 30.44B-¥ 29.42B¥ 23.93B¥ 37.97B¥ 34.36B
Normalized Income
¥ 29.08B-¥ 32.68B¥ 26.47B¥ 32.87B¥ 34.94B
Interest Expense
¥ 23.00M-¥ 16.00M¥ 50.00M¥ 137.00M¥ 180.00M
EBIT
¥ 61.75B-¥ 57.30B¥ 49.29B¥ 75.67B¥ 63.64B
EBITDA
¥ 73.96B¥ 84.74B¥ 71.64B¥ 64.08B¥ 90.36B¥ 77.57B
Currency in JPY

Medipal Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis